活体中puerarin的抗氧化,低血糖和低脂作用

相关实验视频

Updated: May 12, 2025

Preparation of Naringenin Solution for In Vivo Application

Preparation of Naringenin Solution for In Vivo Application

Published on: August 10, 2021

Hong Ruan^1,2, Wanqing Li², Huien Chang²

¹Hubei Key Laboratory of Biologic Resources Protection and Utilization Hubei Minzu University Enshi People's Republic of China.

Food science & nutrition

|May 8, 2025

概括

普埃拉林 (PUE) 显示出显著的抗氧化剂,低血糖和低脂效应. 这项研究证实了PUE.

科学领域:

药理学药理学是指药理学的学科.
生物化学生化学
老年学是指老年学的学科.

背景情况:

普埃拉林 (PUE) 众所周知具有多种药理学活动.
氧化应激,高血糖和高脂血是衰老和相关疾病的关键因素.
对这些疾病的有效治疗干预措施是有需求的.

研究的目的:

调查PUE的体内抗氧化,低血糖和低脂作用.
在衰老,糖尿病和高脂血症模型中评估PUE的潜力.

主要方法:

已确定的D-银糖诱导的衰老,链条毒素 (STZ) 诱导的糖尿病和高脂肪饮食诱导的高脂血症小鼠模型.
在小鼠模型中给予不同剂量的PUE (50,100,200 mg/kg).
评估了抗氧化酶活动,马隆迪阿尔海德 (MDA) 水平,禁食血糖 (FBG),胰岛素和脂质概况.

主要成果:

在老年小鼠中,PUE改善了抗氧化状态并减少了氧化应激.
在糖尿病小鼠中,PUE治疗降低了FBG,并改善了葡萄糖代谢标记物 (肝肝基酶,酸基酶,胰岛素).
在超脂症小鼠中,PUE通过降低总胆固醇,甘油三和LDL-C显著改善了脂质配置,同时增加了HDL-C.

结论:

氨酸 (PUE) 具有显著的抗氧化剂,低血糖和低脂性质.
PUE显示出治疗老化,2型糖尿病和高脂血症的治疗潜力.
需要进一步研究PUE作为代谢和与年龄有关的疾病的治疗方法.

关键词:

衰老的衰老衰老的衰老抗氧化剂是一种抗氧化剂.低血糖症是一种低血糖症.在低脂血症的低脂血症.氧化应激是一种氧化应激.波尔多斯人是什么意思

更多相关视频

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

相关概念视频

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...

Feedback Loops

Feedback Loops

In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...